SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " GLP-1 " 306 found 🔀 AI-powered Shuffle
Some people are getting shut out when it comes to GLP-1 drugs. Here’s why.
People with obesity in the United States are being sorted between haves and have-nots.
‘Ozempic face’ and hair loss: what evidence is there for weight-loss drug side-effects?
Research into GLP-1 medications is not always robust but complaints such as digestive problems are well known
Oral GLP-1 drugs may quiet the brain’s food craving circuit
Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
Harvard Pilgrim, Tufts Health Plan CEO talks GLP-1 weigh-loss drug coverage
A year in, Point32Health CEO sits down to discuss insurance premiums, drug prices, and layoffs.
MRI reveals muscle loss related to weight fluctuations
The research comes as popularity of weight loss medications has intensified in recent years, prompting concern about the loss of muscle mass among some GLP-1 users.
Why aren’t health insurers rushing to cover GLP-1 prescriptions for beneficial weight loss?
In theory, GLP-1 receptor agonist drugs like semaglutide and tirzepatide should save a lot of money for the health insurers that pay for them. As it turns out, the lived reality is not keeping pace with the idealistic expectation.
Novo Nordisk sues GLP-1 rival Eli Lilly over claims of false advertising
Novo Nordisk filed a lawsuit claiming Eli Lilly ran “false and materially misleading” advertisements that ignore recent data. According to Lilly, though, its message is "truthful" and "grounded in the most direct scientific evidence available."
Roundup: LNG exports / Prairieville market / GLP-1 rivalry
Predicted to double: U.S. LNG exports are expected to nearly double by 2031, becoming the country’s second-largest net export industry and contributing an estimated $1.4 trillion to the economy. The growth is driven by abundant shale gas supplies, major Gulf Coast investments and rising global demand, with LNG exports projected to support hundreds of thousands […]
Does Medicare Cover GLP-1s For Weight Loss? What To Know In 2026
Does Medicare Cover GLP-1s For Weight Loss? What To Know In 2026
HHS vaccine committee quietly gets new charter
Lax clinical oversight for online GLP-1 prescriptions, proposed financial help for people who want to quit smoking, and more health news
What really happens at a GLP-1 retreat? I went to find out.
There’s a lot to consider before starting or stopping a GLP-1 medication. This wellness retreat lays it all on the table.
Opinion | Double standard over GLP-1 drugs hits women especially hard
Women experience the effects of obesity in many ways, including heart disease, certain cancers, fertility challenges, maternal health complications, and more severe menopause symptoms.
Weight-loss drugs may improve job prospects and dating odds for one group
A weight-loss specialist says GLP-1 results boost confidence in job interviews and dating, but the study found no clear improvement in well-being.
Does stopping GLP-1s make you gain the weight back? What the science says
A trio of recent studies suggest that some people can keep the weight off.
Jillian Michaels warns against social media health advice as ‘healthmaxxing’ trend goes viral
‘Keeping It Real’ podcast host Jillian Michaels discusses the viral ‘healthmaxxing’ trend and GLP-1 drugs on ‘Fox & Friends.’
Cutting GLP-1 coverage may cost UVM Health more than it saves
UVM Health expects to save $19 million a year by cutting GLP-1 coverage for employees. But does that figure account for the medical costs patients avoid once the treatment works?
Asheville wellness business owner accused of illegally prescribing GLP-1 drug
The owner of an Asheville wellness business is facing 10 felony charges after investigators accused her of diagnosing clients without a medical license in N.C.
GLP-1s are latest wedding trend that has serious implications
Doctors worry the drugs are becoming a wedding fad as online prescribing makes them easier to obtain.
Waiting for insurance coverage for GLP-1s for weight loss? Keep waiting.
The corporations that pay for private employee health insurance are not ready to swallow the high costs of the enormously popular drugs, said the CEO of CVS Health.
GLP-1 drugs linked to long-term benefits for PAD patients
PAD patients treated with GLP-1 receptor agonists lived longer, stayed out of the hospital more and experienced fewer amputations than those given metformin.
GLP-1 drug popularity is outpacing the science, Madison doctor says
Dr. David Harris at UW-Madison says weight loss drugs like Ozempic, Wegovy and Zepbound are safe, so long as patients get the medications from doctors.
Impressive growth of Eli Lilly's obesity business is coming from all over the world
Eli Lilly's international GLP-1 business is booming, giving investors another reason to stick with the stock.
Surprising Mental Health Effects of GLP-1 Weight Loss Drugs
GLP-1 medications may be used to treat select psychiatric disorders.
Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health
Dr. Mehmet Oz backs GLP-1 weight loss medication, but stresses that diet and exercise remain essential, calling obesity the top driver of healthcare costs.
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.
Ipsos poll offers new snapshot of Americans' views on health care and GLP-1 drugs
These 10 Medications May Raise Your Risk of Heat-Related Illness
As summer temperatures climb, so do the risks of heat-related illnesses, particularly for those who take certain medications, such as GLP-1s, diuretics, antidepressants, and beta-blockers. Here's what you need to know to stay safe.
Karpa Health Launches Turnkey Nationwide Telehealth Platform as GLP-1, Peptide, and Hormone Demand Accelerates
The all-in-one platform helps entrepreneurs, clinics, med spas, gyms, and wellness brands launch cash-pay telehealth programs nationwide. TAMPA, FL / ACCESS Newswire / July 3, 2026 / Karpa Health today announced the general availability of its turnkey ...
Dr. Oz on Medicare covering weight loss drugs, America's health innovation
Dr. Mehmet Oz discusses health innovation for America's 250th birthday, highlighting a new initiative where Medicare will cover GLP-1 weight loss medications for $50 a month, aiming to reduce health complications.
Health or Hoax?
Although GLP-1s may cultivate confidence and belonging among gay and bisexual men, they can also reinforce idealized body types that can be unhealthy and socially exclusionary.
What older adults need to know before taking a GLP-1 medication to lose weight
Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep discounts through a temporary federal program called the Medicare GLP-1 Bridge.
Can GLP-1 medications improve health in people with Type 2 diabetes and PAD?
Research Highlights: GLP-1RA (glucagon-like peptide-1 receptor agonist) medications, which are prescribed to treat Type 2 diabetes and to help with weight loss, were found to reduce the number of deaths, amputations and hospitalizations among people...
Ozempic Might Be Making Your Team Less Driven. Here’s the Science
New reports on GLP-1 drugs and the brain’s “wanting” system have direct implications for how leaders motivate, reward, build teams, and sustain culture.
Top GLP-1 prescription indications include sleep apnea, depression and kidney disease, study finds
A report from Trilliant Health looking at payer data found that, as prescriptions for the popular weight loss drugs spike, so rises the number of approved benefits.
Unredacted comments from California hospital lawsuits show stunning admissions and a 'forced' McKinsey collaboration
Who controls the Medicaid market, GLP-1 usage and pizza household costs, and more from Health Care Inc.
GLP-1s 101: What the science says about weight loss, side effects, safety
We asked Stanford Medicine experts to break down everything you need to know about the drugs known as GLP-1s, semaglutide, Ozempic, Wegovy, Zepbound and many more.
Medicare is about to cover GLP-1 drugs for weight loss. Here’s what to know.
The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers have not been disclosed.
Could GLP-1 Drugs Help You Live Longer?
Experts are intrigued by the theory. Here’s what early research suggests.
Could GLP-1 Drugs Help You Live Longer?
Experts are intrigued by the theory. Here’s what early research suggests.
Americans keep poisoning themselves with semaglutide, other weight loss drugs
These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021.
Medicare will soon offer some older Oregonians weight loss drugs for $50 a month. Here’s how it works.
Medicare has long excluded coverage of GLP-1s prescribed solely for weight loss.
GLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.
U.S. health spending rose sharply in 2025, thanks to GLP-1 use and more care
People are getting more care and using lots of GLP-1 drugs, fueling a sharp increase in health care spending.
Science in Seconds: Improving GLP-1
A UConn Health researcher explains how her lab is focusing on how GLP-1 medications affect the brain and how they can be improved for the future
People on GLP-1 medications are exercising less
A new study found that people using weight-loss drugs are doing less exercise, despite feeling healthier. Here's how muscle mass and bone density are affected.
Trouble getting weight loss drugs covered by insurance? Here's what to know
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won't cover it, you have options.
CVS Pharmacy® expands GLP-1 support to lower costs, improve access, and help patients stay on therapy
New $50 monthly copay for eligible Medicare patients, one-on-one pharmacist guidance, and over-the-counter products to help manage common side effects available to support patients
Should everyone be on GLP-1s? What science actually tells us (and doesn't) about the broader health benefits
The laundry list of possible health benefits from GLP-1 drugs seems to get longer by the day, from cancer prevention to combating addiction. But while there’s no question these medications show immense promise beyond their use for diabetes and weight loss, science is still catching up.
Popular weight-loss drugs linked to unexpected male fertility benefit
GLP-1 drugs like semaglutide and liraglutide do not appear to suppress male hormones and may boost fertility in obese men, new research suggests.
Ozempic changed obesity treatment, but experts say the real revolution is next
The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now envision a future where medications, minimally invasive procedures, surgery, and precision medicine work together to deliver better long-term results.
Ozempic and Wegovy linked to surprising drop in violent behavior
A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these medications could affect how people act on impulses, though researchers stress that cause and effect have not been proven.
Ozempic users may be making a major weight-loss mistake, new study suggests
New research finds GLP-1 users significantly reduced physical activity, with daily steps and exercise declining after starting a weight loss medication.
Central Florida counselor discusses connection between mental health and GLP-1 weight-loss drugs
Licensed mental health counselor Shantala Boss explores the connection between GLP-1 medications, disordered eating, and body image concerns.
GLP-1 and weight-loss drugs: How fast-track health solutions are reshaping FMCG
GLP-1 weight-loss drugs are reshaping FMCG as health, body control, and self-optimization trends redefine consumer behaviour across Europe.
Why healthcare stocks are primed to outperform the market: 2 firms
UBS listed three reasons they like the sector, starting with GLP-1 weight-loss drugs.
GLP-1s may help –– not harm –– male fertility
Not only are GLP-1 medications likely not harmful to male fertility, but they may help improve testosterone levels, sperm health and production, study says.
GLP-1s may help –– not harm –– male fertility
Not only are GLP-1 medications likely not harmful to male fertility, but they may help improve testosterone levels, sperm health and production, study says.
Middle-aged adults taking GLP-1s for obesity can save over $192K on lifetime medical costs, higher if they don’t have college degrees, new study finds
The National Bureau of Economic Research paper's lead author hopes putting a dollar value on the benefits of GLP-1s will lead to better access
People taking GLP-1 weight loss drugs like Ozempic started moving less
People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data found that daily step counts and exercise levels dropped after people started these medications, despite successful weight loss. Because the drugs can reduce muscle mass along with fat, the decline in physical activity raises concerns about preserving strength and long-term health.
GLP-1 Drugs May Protect Against Cancer— Here’s What That Means For Public Health
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.
Shaquille O'Neal says he's taking GLP-1s. What it says about body image.
Shaquille O’Neal is the latest among a growing number of celebrities to disclose their usage of GLP-1 medications. What does it mean for body image?
US Workers’ Health Insurance Costs Set to Rise, Survey Finds
Employers say higher prices are forcing them to raise premiums. Some will also stop covering GLP-1s.
Penn study finds GLP-1 use associated with lower breast cancer risk; researchers to launch clinical trial
Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women.
Serena Williams and the coming reckoning with GLP-1s and performance enhancement
GLP-1s are not prohibited; the way they work means they might never be. Anti-doping authorities are still monitoring how athletes use them.
3 ways GLP-1 drugs could be getting better
Drug companies are racing to catch up to Eli Lilly and Novo Nordisk, seeking to require fewer shots or reduce side effects.
Can California afford to cover Ozempic for public employees?
California may require CalPERS health plans to cover Ozempic and other GLP-1 weight-loss drugs. The insurer warns it would cost hundreds of millions of dollars.
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and obesity treatment, a new report shows.
A drug may help people on GLP-1 meds preserve muscle
In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health is unclear.
People are battling 'ghost fat' after losing weight on GLP-1s
Sometimes, seeing isn't believing.
The next goal for weight loss drugs? Fewer injections
Pfizer and Amgen are working on new GLP-1 shots designed to be taken once a month rather than weekly.
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof, and clinical trials are now being planned to test whether these drugs could help prevent breast cancer.
What Serena Williams' GLP-1 use means for longevity and performance
Serena Williams is part of a growing cohort of people using peptides like GLP-1 drugs for longevity, recovery, and performance — not just weight loss.
Mayim Bialik went on a GLP-1. It was a 'nightmare'
Mayim Bialik said she experienced nightmare side effects on a GLP-1. Here's what happened.
Scientists discover why ozempic may not work for some people
Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance." In several clinical trials, carriers were significantly less likely to reach healthy blood sugar targets while taking GLP-1 medications.
The Supply Side: Grocery business responds to GLP-1 use
The rising use of GLP-1 weight-loss drugs is reshaping consumer spending, which impacts food retailers and suppliers. About 1 in 8 U.S. consumers use drugs that reduce appetites and curb...
Decoding the Complex Science of Obesity
GLP-1. GIP. Amylin. Incretins. Peptides. NuSH. It’s not hard to see why the language surrounding modern obesity research sometimes feels like an alphabet soup of scientific terms. But behind each is a growing understanding of how the body regulates hunger, metabolism, energy use, and weight. It’s shaping what we know about how those systems might contribute to obesity.
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and drug-related deaths.
Health insurer Cigna will stop covering GLP-1 weight loss drugs in its employee health plan
CNBC's Becky Quick reports on the latest news.
Illinois hospitals urge Pritzker to quickly sign bill before Eli Lilly cuts off drug discounts
Illinois’ hospital association contends the move by Eli, which has also been threatened by the other large, global GLP-1 manufacturer, Novo Nordisk, is simply an unnecessary roadblock.
Telehealth Booms As Demand For GLP-1s Surges and Questions Mount About Safety, Oversight
By Lauren Sausser and Maia Rosenfeld and KFF Health News HealthDay ReportersWEDNESDAY, JUNE 3, 2026 (HealthDay News) — Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she ...
The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting
Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer prevention and treatment.
The Science Behind the Quest for a Non-Peptide Oral Weight Loss Drug A
A combination of human and artificial intelligence has paved the way for a GLP-1 agonist that is effective when taken by mouth.
GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype?
Ozempic-style drugs have been flagged as possible treatments for cancer, dementia, endo, addiction and more. An expert explains what the evidence really says.
Medicare’s mum on GLP-1s, and Massachusetts sues United
We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.
Vanderbilt Health study explores GLP-1 therapies to improve asthma outcomes in patients with obesity
The study is still recruiting participants. It will conclude in 2026 and provide insight for further investigations into the role GLP-1 agonists may offer in treating respiratory illnesses and overall immune responses.
Which vaccines will curb the Ebola outbreak? WHO debates
The growing Ebola outbreak, the unknowns of microdosing GLP-1s, and more health news from Morning Rounds
An experimental GLP-1 pushes the limits of weight loss. There are risks.
Eli Lilly is developing the the most powerful GLP-1 drug yet. But how much weight loss is too much?
Weight-loss drugs like GLP-1s are easy to buy online raising overdose and safety concerns
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded.
Oura Ring 5 Unveiled With Smaller Design and Blood Pressure Tracking
Oura today unveiled the Oura Ring 5, a significantly smaller smart ring with new health-monitoring capabilities including blood pressure trend detection, nighttime breathing analysis, and tools for GLP-1 medication tracking. The Oura Ring 5 is 40% smaller than its predecessor, measuring 6.09mm wide and 2.29mm thick compared to 7.99mm and 2.88mm on the previous model.
Coming Soon: New Oura Features to Help You Stay Ahead of Your Health
We’re excited to bring a new suite of software innovation to the Oura App, including Health Radar, GLP-1 Insights, Live Activity Tracking, and more.
Oura Ring Is Rolling Out New Health-Tracking Features: When to Unlock Them
Along with the launch of the Oura Ring 5, there will be new health features focusing on blood pressure, nighttime breathing, GLP-1s and more.
Do anti-obesity medications affect bone health?
Learn about a new study to examine if GLP-1 weight loss medications have an effect on bone density.
Expected NC budget won’t restore GLP-1 weight-loss drug coverage for state employees, treasurer says
State Treasurer Brad Briner doesn’t expect North Carolina lawmakers to include funding in the upcoming budget to restore State Health Plan coverage of GLP-1 drugs for weight loss, as costs and competing budget priorities keep the benefit off the table.
Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device giant Dexcom.
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
AI scans 400,000 Reddit posts and finds hidden Ozempic side effects
By analyzing over 400,000 Reddit posts, researchers discovered that users of popular GLP-1 weight-loss drugs frequently discussed unexpected symptoms like menstrual irregularities, chills, and hot flashes. The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss.
People with eating disorders are taking GLP-1s and doctors are alarmed
Providers said they are encountering patients seeking treatment for anorexia, bulimia and binge eating disorder who are taking GLP-1 drugs.
Inflammation may help explain how GLP-1 drugs prevent AFib
Kenneth Bilchick, MD, spoke to Cardiovascular Business about new data he presented at Heart Rhythm 2026.
GLP-1 Drugs Are Causing Frailty | Health for May 22
Plus, why one writer wants everyone to bail on Botox and how natural food colors are linked to health problems